Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

24,260 signal articles · 38 in last 24h · 115,288 total before filter · latest 44m ago
38last 24h
1801last 7d
299● bullish (7d)
170● bearish (7d)
205publishers
AllMacro321Earnings849M&A104Regulatory25Product16Analyst25
✕ clear all filtersticker: ISRGSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Investing.com29d agobearish
Netflix, Intuitive Surgical tumble premarket

Investing.com - U.S. stock index futures fell sharply on Friday, pointing to a second straight day of losses on Wall Street as investors continued to reassess lofty technology valuations following a string of disappointing corporate updates tied to artificial intelligence spending.

Intuitive Surgical Q2 Earnings Call Highlights
MarketBeat30d agoneutral
Intuitive Surgical Q2 Earnings Call Highlights

Intuitive Surgical (NASDAQ:ISRG) reported a solid second quarter of 2026, with management pointing to continued global adoption of its da Vinci, da Vinci SP and Ion platforms, even as U.S. procedure growth moderated and China remained challenging. Chief Executive Officer Dave Rosa said total proced

Intuitive Surgical (NASDAQ:ISRG) Surprises With Q2 CY2026 Sales But Stock Drops
StockStory30d agobearish
Intuitive Surgical (NASDAQ:ISRG) Surprises With Q2 CY2026 Sales But Stock Drops

Medical technology company Intuitive Surgical (NASDAQ:ISRG) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 18.5% year on year to $2.89 billion. Its non-GAAP profit of $2.80 per share was 11.9% above analysts’ consensus estimates. Stock drop is primarily driven by recent declines in overall surgery volumes, which were reported by major healthcare providers, as well as a recent Class II recall of certain da Vinci surgical components.

Why Abbott Stock Is Reimagining Its Future
Trefis30d agoneutral
Why Abbott Stock Is Reimagining Its Future

Abbott’s (ABT) latest financial disclosure reveals a significant strategic evolution that market participants often overlook amidst the focus on quarterly beats. The company is actively executing a structural pivot, shifting its capital allocation and growth dependency away from the volatile Nutrition segment toward high-margin, innovation-led MedTech and specialized diagnostics.

Intuitive Surgical (ISRG) Is Down 6.3% After Class II Recall of da Vinci Components Has The Bull Case Changed?
Simply Wall St.30d agobearish
Intuitive Surgical (ISRG) Is Down 6.3% After Class II Recall of da Vinci Components Has The Bull Case Changed?

In April 2026, Intuitive Surgical voluntarily initiated an ongoing Class II worldwide recall of certain da Vinci surgical system components after discovering an E-brake retainer pin issue that could impede emergency braking or cause uncontrolled column motion, with 454 affected units identified by specific serial numbers. This safety action, alongside growing attention on Intuitive’s AI-enabled da Vinci 5 rollout and competitive pressures in robotic surgery, raises fresh questions about how...

Netflix Earnings, Consumer Sentiment: What to Watch the Rest of the Week
The Wall Street Journal30d agoneutral
Netflix Earnings, Consumer Sentiment: What to Watch the Rest of the Week

Today Earnings (a.m): UnitedHealth, GE Aerospace, U.S. Bancorp, Citizens Financial, Abbott Laboratories, State Street, Taiwan Semiconductor Manufacturing Earnings (p.m.): Netflix, Intuitive Surgical Economic data: Weekly jobless claims, Philadelphia Fed business-outlook survey, retail sales, pending home sales index, business inventories Fed speakers: Fed Vice Chair Philip Jefferson is expected to speak, as is Dallas Fed President Lorie Logan.

The Open Questions On ISRG Stock
Trefis31d agoneutral
The Open Questions On ISRG Stock

Intuitive Surgical's powerful growth is running headlong into some serious market challenges, and how management framed the collision tells you everything about the real risks.

BMO Capital Starts Intuitive Surgical (ISRG) at Outperform
Insider Monkey31d agobullish
BMO Capital Starts Intuitive Surgical (ISRG) at Outperform

Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the 8 Worst Blue Chip Stocks to Buy Now. On July 9, 2026, BMO Capital analyst Vik Chopra initiated coverage of Intuitive Surgical, Inc. (NASDAQ:ISRG) with an Outperform rating and $518 price target. Chopra said the da Vinci 5 upgrade cycle remains in the early innings, procedure growth […]